Macs-based purification of stem cell-derived retinal pigment epithelium
US12241083B2 · kind B2 · utility
0Cited by
5References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2021 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Sep 6, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/03
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided herein are methods of enriching a retinal pigment epithelium (RPE) cell population derived from stem cells. Such a method may comprise removing contaminating cells through the depletion of CD24 positive cells, CD56 positive cells, and/or CD90 positive cells from a starting population of RPE cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.